98%
921
2 minutes
20
The burden of personality disorders (PDs) in China is large and the focus on mental health services is increasing. However, there is a lack of sufficient evidence regarding the prevalence of comorbid PD in psychotic and non-psychotic disorders, and whether PDs have different distributions. We aimed to investigate the PD comorbidity distribution pattern between psychotic and non-psychotic disorders using a clinical population-based study. We conducted a cross-sectional study of 1,497 patients in Shanghai. PDs were screened using the Personality Diagnostic Questionnaire Fourth Edition Plus (PDQ-4+). All patients were interviewed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) Axis II (SCID-II). We compared the differences in PD comorbidities classified as the 10 types of PDs in the DSM-IV, in 531 patients with psychosis and 966 patients with non-psychotic disorders. More than one-third (37%) of patients with psychotic disorders met the criteria of at least one PD. Approximately half (46%) of patients with non-psychotic disorders met the criteria of at least one PD. Patients with non-psychotic disorders were more likely to meet the criteria of borderline (χ = 20.154, < 0.001) and obsessive-compulsive PD (χ = 21.164, < 0.001) diagnoses compared to those with psychotic disorders. In contrast, patients with psychotic disorders were more likely to meet the criteria of paranoid (χ = 11.144, = 0.001) and schizotypal PD (χ = 14.004, < 0.001) diagnoses than those with non-psychotic disorders. PD comorbidity is common and comorbidity distribution pattern is varied in patients with psychotic and non-psychotic disorders, implicating the development of specific strategies that could screen and assess PDs in psychiatric clinical practice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739447 | PMC |
http://dx.doi.org/10.3389/fpsyt.2021.800047 | DOI Listing |
Front Psychiatry
August 2025
Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Introduction: This review systematically assessed the evidence on the effectiveness and safety of pranayama, traditional yogic breathing techniques, for patients diagnosed with mental disorders.
Methods: We searched PubMed, PsycINFO, and Central until April 2024. We calculated standardized mean differences (SMDs) with 95% confidence intervals (CIs) from both intention-to-treat (ITT) and per-protocol (PP) data for symptom severity (primary outcome) and health-related quality of life and depression (secondary outcomes) using Hedges' correction for small samples.
Acta Psychiatr Scand
August 2025
Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio, Finland.
Introduction: Despite well-known diagnostic and neurobiological overlaps between psychopathic traits and schizophrenia, it has remained unclear whether psychopathic traits increase the risk for later schizophrenia. Former studies have proven only a weak correlation between psychopathy and DSM axis I diagnoses.
Methods: We combined data from individuals who underwent forensic psychiatric evaluations (FPEs) at Niuvanniemi Hospital between 1984 and 1993 with the records from the Care Register for Health Care to examine the relationship between psychopathic traits, measured by the Psychopathy Checklist-Revised (PCL-R), and the development of schizophrenia following the evaluation.
Transl Psychiatry
August 2025
Departments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, GA, USA.
Idiopathic psychosis shows considerable biological heterogeneity across cases. The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) used psychosis-relevant biomarkers to identify psychosis Biotypes, which will aid etiological and targeted treatment investigations. Here, our previous approach (Clementz et al.
View Article and Find Full Text PDFIr J Psychol Med
August 2025
School of Medicine, University College Dublin, Dublin, Ireland.
Background: Second-generation antipsychotics (SGAs) are moderately effective treatments for psychotic disorders but are associated with significant weight gain and metabolic complications. These contribute to a nearly 20-year reduction in life expectancy for individuals with enduring psychotic illness. Weight gain can also negatively impact adherence, increase relapse risk, and worsen psychosocial outcomes.
View Article and Find Full Text PDFWest J Emerg Med
July 2025
Mayo Clinic, Department of Emergency Medicine, Rochester Minnesota.
Introduction: Patients who frequently use the emergency department (ED) make up 8% of ED patients annually but account for up to 28% of all ED visits. Frequent ED utilization has been associated with mental health disorders. However, the association between social determinants of health (SDoH) and frequent ED use is not as well understood.
View Article and Find Full Text PDF